Editorial Bioteck
16 November 2026
An interesting randomized study directly comparing ChondroGrid, PRP, and hyaluronic acid in the treatment of knee osteoarthritis has just been published in the scientific journal Future Science OA. The clinical trial was conducted by Prof. Raeissadat (Tehran, Iran) on 135 patients with Kellgren-Lawrence grade 2–3 knee osteoarthritis.
ChondroGrid® is an infiltrative device based on bovine low-molecular-weight hydrolyzed collagen that reinforces the extracellular matrix. Its action promotes pain reduction and the restoration of function in joints and in muscular, tendinous, and ligamentous structures, which are primarily composed of collagen.
At six months, ChondroGrid® demonstrated clinical results comparable to PRP and superior to hyaluronic acid across various functional and quality-of-life parameters, while also recording the highest level of overall satisfaction among patients at the final follow-up.
> Learn more by reading the full article!
Vicenza
Headquarter
via E. Fermi, 49
36057 Arcugnano, Vicenza (VI) - Italy
Tel. +39 0444 289366
Fax: +39 0444 285272
Torino
Multi-function production center
Via G. Agnelli, 3
10020 Riva presso Chieri, Torino (TO) - Italy
Copyright © 2026 Bioteck S.p.A. - Privacy Policy - Cookie Policy